| Item Type | Name |
|
Academic Article
|
The relationship between albuminuria and hormone therapy in postmenopausal women.
|
|
Academic Article
|
Genetic susceptibility contributes to renal and cardiovascular complications of type 2 diabetes mellitus.
|
|
Academic Article
|
Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study.
|
|
Academic Article
|
Effect of race and genetics on vitamin D metabolism, bone and vascular health.
|
|
Academic Article
|
A critical evaluation of glycated protein parameters in advanced nephropathy: a matter of life or death: time to dispense with the hemoglobin A1C in end-stage kidney disease.
|
|
Academic Article
|
Glycated albumin, not hemoglobin A1c, predicts cardiovascular hospitalization and length of stay in diabetic patients on dialysis.
|
|
Academic Article
|
Admixture mapping of coronary artery calcified plaque in African Americans with type 2 diabetes mellitus.
|
|
Academic Article
|
Renal artery calcified plaque associations with subclinical renal and cardiovascular disease.
|
|
Academic Article
|
Heritability of body composition measured by DXA in the diabetes heart study.
|
|
Academic Article
|
Relationship between albuminuria and cardiovascular disease in Type 2 diabetes.
|
|
Academic Article
|
The impact of pedigree structure on heritability estimates for pulse pressure in three studies.
|
|
Academic Article
|
The relationship between C-reactive protein and subclinical cardiovascular disease in the Diabetes Heart Study (DHS).
|
|
Academic Article
|
Genetic factors in common complex renal and cardiovascular diseases.
|
|
Academic Article
|
Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study.
|
|
Academic Article
|
Familial clustering of chronic kidney disease.
|
|
Academic Article
|
Chronic kidney disease: cause and consequence of cardiovascular disease.
|
|
Academic Article
|
Kidney volume associations with subclinical renal and cardiovascular disease: the Diabetes Heart Study.
|
|
Academic Article
|
Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study.
|
|
Academic Article
|
Review of the Diabetes Heart Study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications.
|
|
Academic Article
|
Effects of race on albuminuria and risk of cardiovascular and kidney disease.
|
|
Academic Article
|
Polymorphisms in the Selenoprotein S gene and subclinical cardiovascular disease in the Diabetes Heart Study.
|
|
Academic Article
|
Coronary calcium score predicts cardiovascular mortality in diabetes: diabetes heart study.
|
|
Academic Article
|
Genetic analysis of haptoglobin polymorphisms with cardiovascular disease and type 2 diabetes in the Diabetes Heart Study.
|
|
Concept
|
Cardiovascular Diseases
|
|
Academic Article
|
Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study.
|
|
Academic Article
|
Impact of HDL genetic risk scores on coronary artery calcified plaque and mortality in individuals with type 2 diabetes from the Diabetes Heart Study.
|
|
Academic Article
|
The influence of subclinical cardiovascular disease and related risk factors on cognition in type 2 diabetes mellitus: The DHS-Mind study.
|
|
Academic Article
|
Variants in adiponectin signaling pathway genes show little association with subclinical CVD in the diabetes heart study.
|
|
Academic Article
|
Heart rate-corrected QT interval is an independent predictor of all-cause and cardiovascular mortality in individuals with type 2 diabetes: the Diabetes Heart Study.
|
|
Academic Article
|
Genetic risk score associations with cardiovascular disease and mortality in the Diabetes Heart Study.
|
|
Academic Article
|
Analysis of common and coding variants with cardiovascular disease in the Diabetes Heart Study.
|
|
Academic Article
|
Contributors to mortality in high-risk diabetic patients in the Diabetes Heart Study.
|
|
Academic Article
|
Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.
|
|
Academic Article
|
Cross-sectional analysis of calcium intake for associations with vascular calcification and mortality in individuals with type 2 diabetes from the Diabetes Heart Study.
|
|
Academic Article
|
Prevalence and determinants of electrocardiographic abnormalities in African Americans with type 2 diabetes.
|
|
Academic Article
|
Prediction of mortality using a multi-bed vascular calcification score in the Diabetes Heart Study.
|
|
Academic Article
|
Predictors of all-cause and cardiovascular disease mortality in type 2 diabetes: Diabetes Heart Study.
|
|
Academic Article
|
Analysis of a cardiovascular disease genetic risk score in the Diabetes Heart Study.
|
|
Academic Article
|
Characterization of circulating APOL1 protein complexes in African Americans.
|
|
Academic Article
|
Analysis of the relationships between type 2 diabetes status, glycemic control, and neuroimaging measures in the Diabetes Heart Study Mind.
|
|
Academic Article
|
APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume.
|
|
Academic Article
|
APOL1 Gene Kidney Risk Variants and Cardiovascular Disease: Getting to the Heart of the Matter.
|
|
Grant
|
Subclinical CVD in African American Type 2 Diabetics
|
|
Academic Article
|
The Apolipoprotein L1 Gene and Cardiovascular Disease.
|
|
Academic Article
|
Blood pressure indices and cardiovascular disease mortality in persons with or without diabetes mellitus.
|
|
Academic Article
|
Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.
|
|
Academic Article
|
Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus.
|
|
Academic Article
|
APOL1 renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial.
|
|
Academic Article
|
APOL1 Kidney Risk Variants and Cardiovascular Disease: An Individual Participant Data Meta-Analysis.
|
|
Academic Article
|
Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.
|
|
Academic Article
|
Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.
|
|
Academic Article
|
PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.
|